Congresses

Title Yearsort ascending
Strategies to elucidate the mode of action of the avermectins against mycobacteria 2021
Discovering the mode of action of a novel chemical series active against mycobacteria and other microbial pathogens 2020
Repurposing beta-lactams for Buruli ulcer therapy 2020
Repurposing avermectins for the treatment of infections by non-tuberculous mycobacteria 2020
Development Of An Efficient In Vitro High-Throughput Method To Discover New Combinatorial Therapies Against Non-Tuberculous Mycobacteria 2020
IMPLEMENTATION OF THE HOLLOW FIBER SYSTEM FOR ANTIMICROBIAL RESEARCH 2020
Resistance to selamectin in Mycobacterium smegmatis is associated with changes in the mycobacterial envelope 2020
Fighting Mycobacterium abscessus infection in Cystic Fibrosis patients 2020
Expert campus | Focus on tuberculosis 2020
TOWARDS THE ELUCIDATION OF THE MODE OF ACTION OF A NEW CHEMICAL SERIES WITH ANTIMICROBIAL ACTIVITY 2019
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening 2019
A novel methodology to identify synergistic drug combinations against non-tuberculous mycobacteria in cystic fibrosis 2019
Towards efficient in vitro screening tools to discover new clinical options in the treatment of non-tuberculous Mycobacteria 2019
PRELIMINARY STUDIES FOR THE ELUCIDATION OF THE MODE OF ACTION OF THE AVERMECTINS AS ANTI-TB AGENTS 2019
Towards the elucidation of the rifampicin/beta-lactam synergy in mycobacteria 2019
In vitro profiling of anthelmintic avermectins against non-tuberculous mycobacteria 2019
Sanfetrinem, repurposing an oral beta-lactam with intracellular activity for the treatment of tuberculosis 2019
Nuevos métodos para la búsqueda de combinaciones sinérgicas 2019
Towards the elucidation of the rifampicin/beta-lactam synergy in mycobacteria 2019
New methodologies to test antibiotic susceptibility against emerging pathogens in cystic fibrosis 2019

Pages